Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1992-11-6
|
pubmed:abstractText |
Radioresistance and postirradiation repair of potentially lethal damage (PLD repair) are important factors underlying failure to control local disease in cancer. Dipyridamole (DP) is known as a modifier of the action of cytotoxic drugs. We therefore investigated DP as a potential radiosensitizer and inhibitor of PLD repair in X-irradiated Chinese hamster ovary (CHO) cells in vitro. Exposure to the drug alone resulted in a slight reduction of the clonogenic capacity of the cells. Preincubation for 18 h with 10 and 20 microM DP in cells subcultured at low density, led to a significant radiosensitization. In confluent density-inhibited cultures, preincubation alone as well as pre- and postincubation with 20 microM DP resulted in a significant inhibition of PLD repair. Dipyridamole and related compounds may thus be useful tools for modifying and investigating the response of mammalian cells to radiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0167-8140
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
246-50
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1410580-Animals,
pubmed-meshheading:1410580-Cell Count,
pubmed-meshheading:1410580-Cell Line,
pubmed-meshheading:1410580-Cell Survival,
pubmed-meshheading:1410580-Cricetinae,
pubmed-meshheading:1410580-DNA Damage,
pubmed-meshheading:1410580-DNA Repair,
pubmed-meshheading:1410580-Dipyridamole,
pubmed-meshheading:1410580-Dose-Response Relationship, Drug,
pubmed-meshheading:1410580-Female,
pubmed-meshheading:1410580-Ovary,
pubmed-meshheading:1410580-Radiation-Sensitizing Agents
|
pubmed:year |
1992
|
pubmed:articleTitle |
Radiosensitizing and repair-inhibiting properties of dipyridamole.
|
pubmed:affiliation |
Department of Radiotherapy, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
|
pubmed:publicationType |
Journal Article
|